Nachrichten zur IsoRay Inc. Aktie

IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates

IsoRay (ISR) delivered earnings and revenue surprises of -100% and 56.31%, respectively, for the quarter ended December 2022. Do the…

Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022

Fiscal Calendar Year Changes from June to December Year End Fiscal Calendar Year Changes from June to December Year End...…

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.

Companys focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies...…

Form 8-K Isoray, Inc. For: Jan 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Isoray, Inc. For: Jan 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

Stockholders Approve Proposal One Clearing Way for Consummation of Merger Stockholders Approve Proposal One Clearing Way for Consummation of Merger...…

Form 8-K Isoray, Inc. For: Jan 12

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023

RICHLAND, Wash., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and…

dpa-AFX ProFeed